Acadia Pharmaceuticals buy Mizuho
Start price
23.02.26
/
50%
€20.85
Target price
23.02.27
€29.59
Performance (%)
-8.71%
Price
06.05.26
€18.28
Summary
This prediction is currently active. With a performance of -8.71%, the BUY prediction by Mizuho is trending in the wrong direction. This prediction currently runs until 23.02.27. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -3.916% | -3.916% |
| iShares Core DAX® | 0.224% | 1.487% |
| iShares Nasdaq 100 | 6.047% | 16.188% |
| iShares Nikkei 225® | 5.724% | 11.690% |
| iShares S&P 500 | 2.172% | 8.056% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $29.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€36.02
28.02.25
28.02.25
-19.75%
01.03.25
01.03.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.12.23
29.12.23
€36.19
29.12.24
29.12.24
-42.54%
30.12.24
30.12.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.40
06.11.23
06.11.23
€32.59
06.11.24
06.11.24
-31.70%
07.11.24
07.11.24